Premarket Stock Movements: Peloton, Roivant Sciences, Boston Scientific Among Major Movers
Several stocks experienced notable premarket movements driven by a mix of clinical trial results and analyst actions. Roivant Sciences surged over 24% after positive Phase 2 data for its subsidiary Pulmovant's drug mosliciguat in treating pulmonary hypertension with interstitial lung disease, showing significant reductions in vascular resistance. In contrast, Peloton Interactive fell more than 4%, following a Morgan Stanley downgrade citing structural challenges in the fitness sector. Boston Scientific also declined over 2% due to concerns about sales and profit impacts from a recent cyberattack affecting its long-term financial targets for 2026.
Tickers: $BSX $LMT $NVS $PTON $ROIV $RVTY
Topics: cybersecurity defense earnings_growth medical_devices pharma